Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03965845
Title A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology/Oncology Santa Monica California 90095 United States Details
Emory, Winship Cancer Institute Atlanta Georgia 30322 United States Details
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 United States Details
Rush University Medical Center Chicago Illinois 60612 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Regions Cancer care Center Saint Paul Minnesota 55101 United States Details
Sarah Cannon Research Institute- Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutic, LLC San Antonio Texas 78229 United States Details
University of Wisconsin Clinical Science Center Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field